Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87599-9

By:

• Aldonza, Mark Borris D.;
• Reyes, Roben D. Delos;
• Kim, Young Seo;
• Ku, Jayoung;
• Barsallo, Ana Melisa;
• Hong, Ji-Young;
• Lee, Sang Kook;
• Ryu, Han Suk;
• Park, YongKeun;
• Cho, Je-Yoel;
• Kim, Yoosik

Publication type:

Article